Developing Combination Therapies to Attack Cancer with Isaac Israel Kitov Pharmaceuticals

Published: Aug. 7, 2019, 4:05 p.m.

Isaac Israel, CEO, Kitov Pharmaceuticals talks about how the development of new cancer treatments is an active and rapidly changing field and how Kitov is focusing on making cancer treatments more effective for patients.  They are developing combination therapies that can help overcome cancers' ability to develop resistance to treatment.  Kitov is working on two innovative cancer treatments soon to be advanced to clinical trials.

#oncology #immunoOncology

Kitov Pharmaceuticals

Download the transcript here.